Conversation has moved to delivery: the call's center of gravity is how and when real business converts, not whether it
The model's full reasoning — Q3 2018 call → NOWe need to determine if the center of gravity of the discussion has moved past whether demand exists to the practical mechanics of converting already-real business into results. The call covers multiple products: VIVITROL, ARISTADA, ALKS 5461, ALKS 3831, BIIB098, ALKS 4230. The question asks about the call as a whole. We need to see if the majority of substantive engagement is about conversion mechanics of already-real business. First, identify what is "already real" in the call. VIVITROL and ARISTADA are in-market products with sales. The discussion about them includes growth, market dynamics, policy, etc. But the question is whether the center of gravity is on converting already-real business into results. For VIVITROL, they discuss growth, policy, state initiatives, but also mention expanding sales force, etc. For ARISTADA, they discuss launch of ARISTADA INITIO, hospital formulary additions, sales force expansion. That seems like conversion mechanics of an already-launched product. However, the call also heavily discusses pipeline: ALKS 5461 (pending AdCom, PDUFA), ALKS 3831 (Phase III data readout), BIIB098 (NDA submission), ALKS 4230 (early clinical). These are not yet real business; they are prospective. The question asks if the center of gravity has moved past demand to conversion mechanics. The call includes a lot of discussion about pipeline and regulatory events. Analysts ask about 5461 AdCom, 3831 data, etc. That is about future potential, not current business. We need to assess the overall call. The management spends time on VIVITROL and ARISTADA, but also on pipeline. The analysts' questions: first question about 3831 discontinuation rates, BIIB098 switch candidates. Second about 4230 subcu dosing. Third about 5461 AdCom questions. Fourth about 5461 data and potential scenarios. Fifth about 3831 weight gain, 5461. Sixth about VIVITROL and AdCom. Seventh about ARISTADA head-to-head study. Eighth about 5461 commercial prep. Ninth about VIVITROL acceleration and ICER. So many questions are about pipeline and regulatory. The question asks: "has the CENTER OF GRAVITY of the discussion visibly moved PAST the question of whether demand for the company's offering exists, and ONTO the practical mechanics of converting business that is ALREADY REAL into delivered results?" The offerings that are already real are VIVITROL and ARISTADA.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ERO | Ero Copper Corp. | Q1 2024 | 2024-05-10 | A |
| LINC | Lincoln Educational Services Corporation | Q1 2024 | 2024-05-06 | B+ |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| DXCM | DexCom, Inc. | Q4 2023 | 2024-02-08 | B+ |
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| GOLD | Barrick Gold Corporation | Q3 2023 | 2023-11-02 | C |
| CMG | Chipotle Mexican Grill, Inc. | Q3 2023 | 2023-10-27 | B+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| PTLO | Portillo's Inc. | Q2 2023 | 2023-08-05 | B |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| CTO | CTO Realty Growth, Inc. | Q2 2023 | 2023-07-28 | B |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| SU | Suncor Energy Inc. | Q1 2023 | 2023-05-09 | C+ |
| ULCC | Frontier Group Holdings, Inc. | Q1 2023 | 2023-05-07 | C+ |
| SBRA | Sabra Health Care REIT, Inc. | Q1 2023 | 2023-05-04 | B |
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| ADPT | Adaptive Biotechnologies Corporation | Q4 2022 | 2023-02-14 | C+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| UAL | United Airlines Holdings, Inc. | Q4 2022 | 2023-01-18 | B |
| PKOH | Park-Ohio Holdings Corp. | Q3 2022 | 2022-11-13 | B |
| CHE | Chemed Corporation | Q3 2022 | 2022-11-01 | B+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| HLIO | Helios Technologies, Inc. | Q1 2022 | 2022-05-10 | C |
| BFIN | BankFinancial Corporation | Q1 2022 | 2022-05-06 | A |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| HY | Hyster-Yale Materials Handling, Inc. | Q3 2021 | 2021-11-06 | D |
| KTB | Kontoor Brands, Inc. | Q3 2021 | 2021-11-04 | A |
| LMAT | LeMaitre Vascular, Inc. | Q3 2021 | 2021-10-29 | C+ |
| FFWM | First Foundation Inc. | Q3 2021 | 2021-10-26 | B |
| EGY | VAALCO Energy, Inc. | Q2 2021 | 2021-08-12 | B |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| EMR | Emerson Electric Co. | Q3 2021 | 2021-08-04 | B+ |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| WES | Western Midstream Partners, LP | Q3 2018 | 2018-10-31 | D |
| AU | AngloGold Ashanti's | Q2 2018 | 2018-08-20 | B |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| KIM | Kimco Realty Corporation | Q2 2018 | 2018-07-26 | B+ |
| JBT | John Bean Technologies Corporation | Q2 2018 | 2018-07-26 | B |
| CP | Canadian Pacific Railway Limited | Q2 2018 | 2018-07-19 | B+ |
| MKC | McCormick & Company, Incorporated | Q2 2018 | 2018-06-28 | C+ |
| FSS | Federal Signal Corporation | Q1 2018 | 2018-05-12 | A |
| EPAM | EPAM Systems, Inc. | Q4 2017 | 2018-02-16 | B |
| AOSL | Alpha and Omega Semiconductor Limited | Q2 2018 | 2018-02-07 | B |
| CPK | Chesapeake Utilities Corporation | Q3 2017 | 2017-11-10 | A |
| RACE | Ferrari N.V. | Q3 2017 | 2017-11-02 | C+ |
| ABM | ABM Industries Incorporated | Q2 2017 | 2017-06-08 | B |
| FIX | Comfort Systems USA, Inc. | Q1 2017 | 2017-04-30 | A |
| GPOR | Gulfport Energy Corporation | Q4 2016 | 2017-02-14 | A |
| ARAY | Accuray Incorporated | Q4 2016 | 2016-08-17 | B |
| LBTYK | Liberty Global's | Q1 2016 | 2016-05-10 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
GOLD · Q3 2023 → YESThe question is: Has the center of gravity of the discussion moved past whether demand exists, onto the practical mechanics of converting already real business into delivered results? YES The transcript shows the center of gravity has shifted to execution mechanics for already-committed operations and growth projects. Management details current production (up QoQ at NGM, Loulo-Gounkoto, Kibali), specific ramp-up challenges and fixes at Pueblo Viejo (gearbox failures, conveyor issues, temporary 70-75% throughput solutions, new assemblages arriving end-2023), tailings permitting, and phased construction at RekoDiq/Lumwana (2025 start, 2028/2026 first production). Analysts press on Q4 production, 2024 profiles (PV >800koz despite delays), recovery rates 70% to design, capital sequencing ($2.5B 2024, peaks 2025-26), and conversion timing (downtimes, relocations, training).
LBTYK · Q1 2016 → YESThe question is: Has the center of gravity of the discussion moved past whether demand exists, onto the practical mechanics of converting already real business into delivered results? YES The call as a whole satisfies both conditions. Management repeatedly frames the business as already real—existing customer bases, price increases already implemented across two-thirds of the footprint, 210,000 new-build homes added in Q1, 330,000 premises released under Project Lightning, 100,000 postpaid mobile subs added organically, BASE integration underway, and the Cable & Wireless transaction closing next week.
DXCM · Q4 2023 → YESThe question is: has the CENTER OF GRAVITY of the discussion visibly moved PAST the question of whether demand for the company's offering exists, and ONTO the practical mechanics of converting busines...